Keyphrases
100,000 Genomes Project
18%
Apremilast
75%
Blister Fluid
21%
Budget Impact
12%
De-novo mutations
75%
Developmental Disorders
75%
Diagnostic Odyssey
12%
Diagnostic Performance
79%
Diagnostic Utility
18%
Economic Evaluation
75%
Edinburgh
18%
Epidermis
21%
Epidermolysis Bullosa
75%
Exome
29%
Exome Sequencing
37%
Family Trios
12%
Gene Panel
75%
Gene-based
18%
Genetic Laboratory
18%
Genetic Testing
43%
Genome Analysis
18%
Genome Sequencing
100%
Genomic Data
18%
Genomic Medicine
24%
Genomics England
37%
Implications for Future
75%
Inflammation
21%
Inherited Condition
75%
Minimal Cost
18%
New Diagnosis
18%
NHS Scotland
31%
Novel Developments
12%
Parental Age
21%
Peace of Mind
12%
Publicly Funded Healthcare Systems
75%
Rare Diseases
75%
Rare Phenotype
18%
Regional Service
18%
Scotland
93%
Scottish
24%
Sequence Data
18%
Singleton
24%
Structural Variation
18%
T Helper 17 (Th17)
75%
Trio Exome
18%
User Value
12%
Valuation Studies
12%
Variant Calling
18%
Variant Prioritization
37%
Whole Genome Sequencing
75%
Biochemistry, Genetics and Molecular Biology
Exome
75%
Exome Sequencing
18%
Gene Function
37%
Genetic Screening
56%
Genetics
37%
Genome Sequencing
100%
Genomics
100%
Parental Age
75%
Prevalence
75%
Protein Function
37%
Relatedness
37%
Whole Genome Sequencing
75%
Medicine and Dentistry
Apremilast
75%
Blister
10%
Blister Fluid
21%
Cytokine
21%
Disease
21%
Eosinophil
10%
Epidermolysis Bullosa Simplex
75%
Genetic Disorder
10%
Immunohistochemistry
10%
Lymphocyte
10%
Neutrophil
10%
Prospective Study
10%
Real-Time Polymerase Chain Reaction
10%
Retrospective Study
10%
Skin Biopsy
10%
Skin Blistering
21%
T Helper 17 Cell
10%